TrialBMJ open2016

Multicentre open-label randomised controlled trial to compare colistin alone with colistin plus meropenem for the treatment of severe infections caused by carbapenem-resistant Gram-negative infections (AIDA): a study protocol.

Yaakov Dickstein et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.